Star Health Share Price Target: Star Health and Allied Insurance Company Limited, established in 2006 and headquartered in Chennai, Tamil Nadu, operates within the health insurance sector. Its offerings include health insurance, travel insurance, and accidental insurance. In this article, we will outline the projected share price targets for Star Health in 2025, examining the company’s stock performance since its market debut in 2021. We will also discuss other critical factors, such as the company’s financial health and insights from market experts, to assess potential returns on investment.
Latest Updates on Star Health Share Price Target
As of today, Star Health’s share price has risen by 1.22%. While this increase is modest, it may suggest a positive trend for the STARHEALTH NSE stock in the coming months. Geojit Financial Services, a well-known market advisory firm, has recommended Star Health shares for purchase, projecting a target price of ₹738. Star Health Share Price Target 2024 500.07, 2025 553.08, 2026 557.15, 2027 602.34, 2028 663.20, 2029 720.66, To 2030 773.69.
Star Health Share Price Target 2024 To 2030 Forecast
| Year | Maximum Target (₹) | Minimum Target (₹) |
| 2024 | 650.56 | 500.07 |
| 2025 | 761.00 | 553.08 |
| 2026 | 874.01 | 557.15 |
| 2027 | 988.44 | 602.34 |
| 2028 | 1,109.47 | 663.20 |
| 2029 | 1,223.44 | 720.66 |
| 2030 | 1,335.10 | 773.69 |
See More:
IRFC Share Price Target
RVNL Share Price Target
Mazagon Dock Share Price Target
Star Health Share Price Target 2024, 2025, 2026, 2027, 2028, 2029 To 2030
Star Health Share Price Target 2024 500.07, 2025 553.08, 2026 557.15, 2027 602.34, 2028 663.20, 2029 720.66, To 2030 773.69.
Share Price Targets for 2024
| Month | Maximum Target (₹) | Minimum Target (₹) |
| September | 623.58 | 485.77 |
| October | 630.27 | 490.09 |
| November | 642.45 | 496.90 |
| December | 650.56 | 500.07 |
Share Price Targets for 2025
| Month | Maximum Target (₹) | Minimum Target (₹) |
| January | 662.11 | 504.48 |
| February | 670.90 | 507.73 |
| March | 677.56 | 511.80 |
| April | 689.33 | 516.90 |
| May | 700.81 | 518.02 |
| June | 711.26 | 523.25 |
| July | 720.46 | 529.45 |
| August | 730.77 | 535.62 |
| September | 735.05 | 540.80 |
| October | 742.05 | 544.27 |
| November | 753.17 | 548.28 |
| December | 761.00 | 553.08 |
See More: Suzlon Share Price Target
Share Price Targets from 2026 to 2030
| Year | Maximum Target (₹) | Minimum Target (₹) |
| 2026 | 874.01 | 557.15 |
| 2027 | 988.44 | 602.34 |
| 2028 | 1,109.47 | 663.20 |
| 2029 | 1,223.44 | 720.66 |
| 2030 | 1,335.10 | 773.69 |
Miscellaneous Information for Star Health 2024
| Metric | Value |
| 52 Week High-Low | 647.00 – 454.80 |
| P/E Ratio | 41.39 |
| Reserves & Surplus | 5,798.71 cr |
| Borrowings | 470.00 cr |
| Basic & Diluted EPS | 14.48 & 14.49 |
| Book Value | 109.08 |
| Shares Outstanding | 585.28 M shares |
See More: Glenmark Share Price Target
Financial Overview of Star Health 2024
| Metric | Value | Change (YOY) |
| Revenue | 140.24 B INR | +15.90% |
| Operating Expense | 23.27 B INR | +8.07% |
| Net Income | 8.45 B INR | +36.60% |
| Net Profit Margin | 6.03 | +18.00% |
| Earnings Per Share | 14.19 | +36.31% |
| EBITDA | 12.32 B INR | +27.38% |
| Total Assets | 180.54 B INR | +10.37% |
| Total Liabilities | 113.23 B INR | +15.90% |
| Total Equity | 67.32 B INR | – |
See More: Cochin Shipyard Share Price Target
Shareholding Pattern of Star Health
| Company | Market Cap (cr INR) |
| Star Health | 35,655 |
| ITC | 653,834 |
| Grasim | 183,816 |
| RIL Partly Paid | 78,137 |
| Linde India | 73,194 |
See More: ONGC Share Price Target
Considerations Before Investing in Star Health NSE Stock
The health insurance sector in India has shown robust growth, with the industry projected to reach USD 222 billion by 2026. As new companies enter the market, established players are likely to benefit from the sector’s expansion. Star Health is financially sound, reporting increases in both revenue and net income of 15% and 36%, respectively, in 2024. Despite its solid financial performance, the stock has struggled since its IPO due to initial overpricing, a common trend among many newly listed companies. Investors may need to adopt a long-term approach to realize substantial returns on their investments in Star Health.
